- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00947362
Rationale for New Topical Anthroponotic Cutaneous Leishmaniasis (ACL) Treatment in Kabul (rtt-ACL)
July 27, 2009 updated by: Waisenmedizin e. V. Promoting Access to Essential Medicine
Phase 2 Study Electrothermocauterisation of Afghan Patients With Anthroponotic Cutaneous Leishmaniasis With and Without Pharmaceutical Chlorite Listed in the German Drug Codex (DAC N-055)
The aim of the randomized double blind trial with 134 patients presenting old world cutaneous leishmaniasis is:
- to evaluate the clinical efficacy of electro-thermo-cauterisation (ETC) followed by moist wound treatment versus ETC followed by moist wound treatment plus 0.05 % pharmaceutical chlorite that has been used in three European countries (Germany, Austria and Switzerland) in wound care management for more than 20 years;
- to judge whether early wound care management would present a viable improvement to the actual anti-parasitic treatments mostly neglecting the chronic wound problem and to evaluate its long-term effect on immunity through relapse control 6 months after wound healing.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
134
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kabul, Afghanistan
- German Medical Service
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- at least one suspected lesion positive in Giemsa smear
Exclusion Criteria:
- patients previously treated for leishmania
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ETC + DAC N-055
|
moist wound treatment plus 0.05 % pharmaceutical chlorite
|
Active Comparator: ETC + physiological saline
|
physiological saline
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Wound closure time
|
Secondary Outcome Measures
Outcome Measure |
---|
Leishmania load parasites per gram of tissue before and after treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2004
Study Completion
December 1, 2007
Study Registration Dates
First Submitted
July 24, 2009
First Submitted That Met QC Criteria
July 27, 2009
First Posted (Estimate)
July 28, 2009
Study Record Updates
Last Update Posted (Estimate)
July 28, 2009
Last Update Submitted That Met QC Criteria
July 27, 2009
Last Verified
July 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 169/04
- No grant or contract number
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wound Healing
-
University of Witten/HerdeckeKCI Europe Holding B.V.CompletedImpaired Wound Healing | Wound Healing Disorder | Abdominal Wound Healing Disorder | Abdominal Wound Healing Impairment | Acute Postsurgical Subcutaneous WoundBelgium, Germany
-
Universidade Estadual Paulista Júlio de Mesquita...RecruitingWound Healing | Palate; WoundBrazil
-
First Affiliated Hospital, Sun Yat-Sen UniversityRecruiting
-
3MRecruiting
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Riyadh Elm UniversityUnknown
-
Icahn School of Medicine at Mount SinaiTerminated
-
OcuNexus Therapeutics, Inc.Completed
-
Stratpharma AGUniversity Hospital, GenevaCompleted
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedWound HealingUnited States
Clinical Trials on Electro-thermo-coagulation
-
Waisenmedizin e. V. Promoting Access to Essential...University of Erlangen-Nürnberg Medical School; German Federal Ministry of... and other collaboratorsCompletedWound HealingAfghanistan
-
Chinese University of Hong KongThe First Affiliated Hospital of Nanchang University; Beijing Friendship Hospital and other collaboratorsNot yet recruitingBleeding Peptic Ulcer
-
Chinese University of Hong KongNorth District Hospital; King Chulalongkorn Memorial Hospital; Changi General...CompletedAcute Upper Gastrointestinal BleedingChina
-
Chinese University of Hong KongBeijing Friendship Hospital; The First Affiliated Hospital of Soochow University and other collaboratorsCompletedAcute Upper Gastrointestinal Bleeding | Tumor BleedingHong Kong, China, Australia
-
Hallym University Kangnam Sacred Heart HospitalUnknownNasotracheal IntubationKorea, Republic of
-
Hubei Hospital of Traditional Chinese MedicineCompletedObesity, AbdominalChina
-
Guang'anmen Hospital of China Academy of Chinese...Ministry of Science and Technology of the People´s Republic of ChinaCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedEpileptic SyndromesFrance
-
Hillerod Hospital, DenmarkThe Lundbeckfoundation; BiofieldsCompleted
-
University of California, IrvineRecruiting